Search for: "STATE v. SMALL" Results 1441 - 1460 of 16,875
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Nov 2022, 11:32 pm by Florian Mueller
Even if there was any prejudice (which, again, is far from clear), they could be addressed without negating the right to repair.Today the Munich I Regional Court will hold two Ericsson v. [read post]
21 Nov 2022, 2:18 am by INFORRM
The bill would introduce new powers to deal with serious disruption caused by protesters, including allowing the Secretary of State to bring civil proceedings against campaigners. [read post]
20 Nov 2022, 9:53 am by David Kopel
Supreme Court affirmed in New York State Rifle and Pistol Association v. [read post]
19 Nov 2022, 7:21 am by Anna Bower
And he cites Georgia Court of Appeals precedent, Kenerly v. [read post]
18 Nov 2022, 6:16 am by Brad Carney, Olivia B. Hoff
Deterring strategic attacks against the United States, allies, and partners. [read post]
16 Nov 2022, 4:00 am by Guest Author
” Although not every lawyer or legal academic adhering to the Court’s views is on the political right, the ascendancy of both contemporary originalism and unitary executive theory has everything to do with their attractiveness to conservatives in the wake of Brown v. [read post]
15 Nov 2022, 5:56 am by Jonathan Hafetz
Then, when the Supreme Court effectively confirmed that CIA black sites were unlawful in 2006 by ruling in Hamdan v. [read post]
15 Nov 2022, 2:17 am by Kurt R. Karst
By Véronique Li, Senior Medical Device Regulation Expert & Philip Won —In our last blog post, we advised medical device companies to consider applying to FDA’s Small Business Program to help with the noticeably higher user fees for FY2023. [read post]
14 Nov 2022, 2:55 am by Gabriele Girardello
If that is the case, in fact, the second medicinal product would not enjoy the data and market exclusivity as provided for by the Directive.The General Court expressed a restrictive view, stating that the first authorisation of a medicinal product containing a certain active ingredient used in combination for a certain disease prevents the enjoyment of market and data exclusivity on a second medicinal product using the same mono-substance for a different use. [read post]